One significant study examined the economic burden of FGM/C in 27 high-prevalence countries, revealing that the healthcare costs associated with FGM/C are substantial and projected to rise ...
Our second report (coming soon) systemically reviews available data from which FGM prevalence levels might be established. Despite serious inadequacies in the data available, there is sufficient ...